# Apatinib for Inoperable Advanced Chondrosarcoma

> **NCT04260113** · NA · COMPLETED · sponsor: **Peking University People's Hospital** · enrollment: 40 (actual)

## Conditions studied

- Efficacy
- Toxicity, Drug

## Interventions

- **DRUG:** Apatinib Mesylate

## Key facts

- **NCT ID:** NCT04260113
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-04-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04260113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04260113, "Apatinib for Inoperable Advanced Chondrosarcoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04260113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*